IL17A and metabolic dysfunction-associated steatotic liver disease: The top 10 KEGG pathways include: Pathways in cancer, Lipid and atherosclerosis, Efferocytosis, Coronavirus disease-COVID-19, IL-17 signaling pathway, Endocrine resistance, MAPK signaling pathway, Prolactin signaling pathway, Non-alcoholic fatty liver disease, Colorectal cancer.